Capacity of advanced glycosidation end products in patients on hemodialysis

Shinji Fukuda, Yoshio Nagake, Katsumi Kawano, Haruo Ichikawa, Kenichi Shikata, Hirofumi Makino

Research output: Contribution to journalArticle

Abstract

Advanced glycation endproducts (AGEs) are formed during non-enzymatic glycation and oxidation reactions. Acidic β2-MG in amyloid fibrils of patients with dialysis related amyloidosis contained early Amadori products and AGEs. In the present study, we measured serum AGEs levels by enzyme-linked immunosorbent assays (ELISA) before and after hemodialysis (HD), and examined the changes in serum AGE levels during a single session of HD therapy, and whether serum AGE level was influenced by the type of dialyzer or not. Ninety-five patients on HD were included in this study. We used high-flux dialyzers such as cellulose triacetate or polysulfone dialyzers, and low-flux dialyzers such as ethylene vinyl alcohol or regenerated cellulose (RC) dialyzers. We measured serum level of AGE and the capacity of AGEs production contained both early Amadori products and AGE. Serum AGEs level was significantly decreased during HD. The reduction rate in serum AGEs level with high-flux dialyzers was higher than that with low-flux dialyzers. The capacity of AGEs production before HD in high-flux dialyzers showed less than those with RC dialyzers. Moreover, the capacity of AGEs production correlated positively with indices of glycemic control. In conclusion, the reduction rates of serum AGE levels in high-flux dialyzers were higher than that with low-flux dialyzers. The capacity of AGEs production might be dependent upon the characteristics of dialysis membrane materials. Furthermore, as the capacity of AGEs production was correlated with indices of glycemic control, the production of early Amadori products might partly associated with hyperglycemia.

Original languageEnglish
Pages (from-to)309-325
Number of pages17
JournalJournal of Medicine
Volume33
Issue number5-6
Publication statusPublished - 2002

Fingerprint

Renal Dialysis
Serum
Glycemic Index
Cellulose
Dialysis
Amyloidosis
Amyloid
Hyperglycemia
Enzyme-Linked Immunosorbent Assay
Alcohols
Membranes

Keywords

  • Advanced glycation endproducts (AGEs)
  • Dialyzer
  • ELISA
  • Glycemic control
  • Hemodialysis
  • The capacity of AGE production

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Capacity of advanced glycosidation end products in patients on hemodialysis. / Fukuda, Shinji; Nagake, Yoshio; Kawano, Katsumi; Ichikawa, Haruo; Shikata, Kenichi; Makino, Hirofumi.

In: Journal of Medicine, Vol. 33, No. 5-6, 2002, p. 309-325.

Research output: Contribution to journalArticle

Fukuda, S, Nagake, Y, Kawano, K, Ichikawa, H, Shikata, K & Makino, H 2002, 'Capacity of advanced glycosidation end products in patients on hemodialysis', Journal of Medicine, vol. 33, no. 5-6, pp. 309-325.
Fukuda, Shinji ; Nagake, Yoshio ; Kawano, Katsumi ; Ichikawa, Haruo ; Shikata, Kenichi ; Makino, Hirofumi. / Capacity of advanced glycosidation end products in patients on hemodialysis. In: Journal of Medicine. 2002 ; Vol. 33, No. 5-6. pp. 309-325.
@article{9b644423c4bc4d7581a079a8462c1813,
title = "Capacity of advanced glycosidation end products in patients on hemodialysis",
abstract = "Advanced glycation endproducts (AGEs) are formed during non-enzymatic glycation and oxidation reactions. Acidic β2-MG in amyloid fibrils of patients with dialysis related amyloidosis contained early Amadori products and AGEs. In the present study, we measured serum AGEs levels by enzyme-linked immunosorbent assays (ELISA) before and after hemodialysis (HD), and examined the changes in serum AGE levels during a single session of HD therapy, and whether serum AGE level was influenced by the type of dialyzer or not. Ninety-five patients on HD were included in this study. We used high-flux dialyzers such as cellulose triacetate or polysulfone dialyzers, and low-flux dialyzers such as ethylene vinyl alcohol or regenerated cellulose (RC) dialyzers. We measured serum level of AGE and the capacity of AGEs production contained both early Amadori products and AGE. Serum AGEs level was significantly decreased during HD. The reduction rate in serum AGEs level with high-flux dialyzers was higher than that with low-flux dialyzers. The capacity of AGEs production before HD in high-flux dialyzers showed less than those with RC dialyzers. Moreover, the capacity of AGEs production correlated positively with indices of glycemic control. In conclusion, the reduction rates of serum AGE levels in high-flux dialyzers were higher than that with low-flux dialyzers. The capacity of AGEs production might be dependent upon the characteristics of dialysis membrane materials. Furthermore, as the capacity of AGEs production was correlated with indices of glycemic control, the production of early Amadori products might partly associated with hyperglycemia.",
keywords = "Advanced glycation endproducts (AGEs), Dialyzer, ELISA, Glycemic control, Hemodialysis, The capacity of AGE production",
author = "Shinji Fukuda and Yoshio Nagake and Katsumi Kawano and Haruo Ichikawa and Kenichi Shikata and Hirofumi Makino",
year = "2002",
language = "English",
volume = "33",
pages = "309--325",
journal = "Journal of Medicine",
issn = "0025-7850",
publisher = "S. Karger AG",
number = "5-6",

}

TY - JOUR

T1 - Capacity of advanced glycosidation end products in patients on hemodialysis

AU - Fukuda, Shinji

AU - Nagake, Yoshio

AU - Kawano, Katsumi

AU - Ichikawa, Haruo

AU - Shikata, Kenichi

AU - Makino, Hirofumi

PY - 2002

Y1 - 2002

N2 - Advanced glycation endproducts (AGEs) are formed during non-enzymatic glycation and oxidation reactions. Acidic β2-MG in amyloid fibrils of patients with dialysis related amyloidosis contained early Amadori products and AGEs. In the present study, we measured serum AGEs levels by enzyme-linked immunosorbent assays (ELISA) before and after hemodialysis (HD), and examined the changes in serum AGE levels during a single session of HD therapy, and whether serum AGE level was influenced by the type of dialyzer or not. Ninety-five patients on HD were included in this study. We used high-flux dialyzers such as cellulose triacetate or polysulfone dialyzers, and low-flux dialyzers such as ethylene vinyl alcohol or regenerated cellulose (RC) dialyzers. We measured serum level of AGE and the capacity of AGEs production contained both early Amadori products and AGE. Serum AGEs level was significantly decreased during HD. The reduction rate in serum AGEs level with high-flux dialyzers was higher than that with low-flux dialyzers. The capacity of AGEs production before HD in high-flux dialyzers showed less than those with RC dialyzers. Moreover, the capacity of AGEs production correlated positively with indices of glycemic control. In conclusion, the reduction rates of serum AGE levels in high-flux dialyzers were higher than that with low-flux dialyzers. The capacity of AGEs production might be dependent upon the characteristics of dialysis membrane materials. Furthermore, as the capacity of AGEs production was correlated with indices of glycemic control, the production of early Amadori products might partly associated with hyperglycemia.

AB - Advanced glycation endproducts (AGEs) are formed during non-enzymatic glycation and oxidation reactions. Acidic β2-MG in amyloid fibrils of patients with dialysis related amyloidosis contained early Amadori products and AGEs. In the present study, we measured serum AGEs levels by enzyme-linked immunosorbent assays (ELISA) before and after hemodialysis (HD), and examined the changes in serum AGE levels during a single session of HD therapy, and whether serum AGE level was influenced by the type of dialyzer or not. Ninety-five patients on HD were included in this study. We used high-flux dialyzers such as cellulose triacetate or polysulfone dialyzers, and low-flux dialyzers such as ethylene vinyl alcohol or regenerated cellulose (RC) dialyzers. We measured serum level of AGE and the capacity of AGEs production contained both early Amadori products and AGE. Serum AGEs level was significantly decreased during HD. The reduction rate in serum AGEs level with high-flux dialyzers was higher than that with low-flux dialyzers. The capacity of AGEs production before HD in high-flux dialyzers showed less than those with RC dialyzers. Moreover, the capacity of AGEs production correlated positively with indices of glycemic control. In conclusion, the reduction rates of serum AGE levels in high-flux dialyzers were higher than that with low-flux dialyzers. The capacity of AGEs production might be dependent upon the characteristics of dialysis membrane materials. Furthermore, as the capacity of AGEs production was correlated with indices of glycemic control, the production of early Amadori products might partly associated with hyperglycemia.

KW - Advanced glycation endproducts (AGEs)

KW - Dialyzer

KW - ELISA

KW - Glycemic control

KW - Hemodialysis

KW - The capacity of AGE production

UR - http://www.scopus.com/inward/record.url?scp=34648828066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34648828066&partnerID=8YFLogxK

M3 - Article

VL - 33

SP - 309

EP - 325

JO - Journal of Medicine

JF - Journal of Medicine

SN - 0025-7850

IS - 5-6

ER -